Medical & Anti-Doping
The IGF Anti-Doping Committee, that consists of representatives from National Golf Federation members and Professional members of the IGF, has been established to oversee and advise on all aspects related to anti-doping and on issues relating to doping control and general areas of responsibility include:
- To regulate and undertake doping control.
- To advise and assist in the practical enforcement of the IGF Anti-Doping Policy
- To consider and process, via the IGF anti-doping office, requests from competitors for dispensation for Therapeutic Use Exemptions (TUE) in accordance with the procedures in the World Anti-Doping Code International Standard for Therapeutic Use Exemptions, and to issue such Certifications of Approval.
- To validate and formulate the Therapeutic Use Exemptions Process, for competitors seeking to compete in the Olympic Golf Competition, and to act on behalf of such competitors in confidential negotiations with the IOC Medical Commission;
- To assist in doping control at IGF-sanctioned events as required.
- To formulate and publish anti-doping rules and to assist in putting them into effect.
- To provide advice and recommendations on request to the Council, Captains and National Golf Federations.
- To inform and advise the IGF in respect of the implications and implementation of World Anti-Doping Code, and all its provisions
- To ensure that such annual changes as are made to the World Anti-Doping Code List of Prohibited Substances and Methods are published and made known to Member National Authorities, so that these may be disseminated to competitive golfers worldwide
- To assist with the production of educational updates relating to drug use in sport for athletes, coaches and other IGF stakeholders
- To contribute to the body of IGF knowledge on all matters of drugs in sport
IGF Anti-Doping Rules
The IGF Anti-Doping policy is compliant with the 2015 World Anti-Doping Code (WADA) and can be found below in pdf format. The rules of anti-doping in golf are thoroughly explained in the IGF Anti-Doping Policy.
Under the IGF Anti-Doping Programme, players are tested for banned substances and methods in accordance with the Prohibited List of the World Anti-Doping Code.
- IGF 2016 Anti-Doping Policy
- IGF 2017 Anti-Doping Policy
- WADA 2018 Prohibited List – To view the changes made to the 2018 Prohibited List, please see the 2018 Summary of Major Modifications and Explanatory Notes.
- WADA 2017 Prohibited List – To view the changes made to the 2017 Prohibited List, please see the 2017 Summary of Major Modifications and Explanatory Notes.
- Player Guide for the 2014 World Amateur Team Championships
- Prohibited List of Substances and Methods – explanation
- Notice to Athletes about processing of personal information in ADAMS
- IGF Anti-Doping Handbook – Rio2016 Olympic Games
- IOC Anti-Doping Rules for Rio2016 Olympic Games
Therapeutic Use Exemptions
If you have an illness or condition that requires a medication containing a substance that is on the Prohibited List, a Therapeutic Use Exemption (TUE) may be granted that enables you to take the medication without committing a Doping Offence.
- IGF Guide to Therapeutic Use Exemptions
- IGF Therapeutic Use Exemption (TUE) form
- IGF Automatic Recognition of TUEs
- The Risk of Using Supplements
Youth Olympic Games
- Anti Doping Information Sheet
- Ebola Virus Disease Fact Sheet
- Anti Doping Handout (English)
- Anti Doping Handout (Français)
- Anti Doping Rules (English)
- Anti Doping Rules (Français)
- Technical Procedure-final (English)
- Technical Procedure-final (Français)
In this section you can find out more about the IGF Anti-Doping Programme including information on types of prohibited substances, nutrition and links to other Anti-Doping websites.
The IGF recognises that education contributes to a long-term solution to prevent doping through effective values-based educational programmes that encourage people not to dope and create a strong anti-doping culture.
The IGF encourages its National Federations to implement education programmes promoting the anti-doping message at their events.
The IGF Athlete Outreach Programme educates athletes and their entourage at international events providing information about the dangers and consequences of doping
The World Anti-Doping Code
- The World Anti-Doping Code
- Athletes Reference Guide to the 2015 World Anti-Doping Code
- WADA International Standard for Testing and Investigations
- WADA International Standard for Laboratories
- WADA International Standard for Therapeutic Use Exemption
- WADA International Standard for the Protection of Privacy and Personal Information
- WADA Significant Changes between 2009 and 2015 Code
- WADA 2016 Prohibited List
WADA at a glance series
- WADA at a Glance Anti-doping (PDF)
- WADA at a Glance Therapeutic Use Exemptions (PDF)
- WADA at a Glance The Doping Control Process (PDF)
Links to medication check
Phone: +41 21 623 12 12
IGF Statement of Zika
IGF Advice on vaccinations
World Health Organisation Statement on Zika Virus_May 2016
WHO Information for travellers visiting Zika affected countries_May 31st, 2016
IOC Health Advice relevant to the Rio2016 Olympic Games, July 11th, 2016
WHO Statement on Zika, June 14th, 2016
The Olympic Movement Medical Code, adopted by the IGF.
Rio2016 Update on Zika, June 2016
IGF Update on Zika, June 14th, 2016
The IGF Event Coverage Guidelines are intended to assist event organisers to deliver safe events and set a standard for the medical cover at golf competitions. The principals and guidance provided can be also used as the basis for any golf event cover but may be modified to adhere to local and national legislation, which is present in many countries.